Related Articles
Knockdown of eukaryotic translation initiation factor 5A2 enhances the therapeutic efficiency of doxorubicin in hepatocellular carcinoma cells by triggering lethal autophagy
GC7 enhances cisplatin sensitivity via STAT3 signaling pathway inhibition and eIF5A2 inactivation in mesenchymal phenotype oral cancer cells
Co-treatment with gemcitabine and nab-paclitaxel exerts additive effects on pancreatic cancer cell death
MicroRNA‑33a‑5p overexpression sensitizes triple‑negative breast cancer to doxorubicin by inhibiting eIF5A2 and epithelial‑mesenchymal transition
Prognostic significance of the expression of nuclear eukaryotic translation initiation factor 5A2 in human melanoma